This website uses only technical or equivalent cookies.
For more information click here.

About the Journal

 

EDITORIAL POLICY

  1. Editorial line

  2. Focus, Scope and Objective
  3. Open Access Policy
  4. Peer Review Process
  5. Submission on line
  6. Pre- and post-prints
  7. Systematic Reviews
  8. Clinical Trials

01. Editorial line

Official Journal of the “Società Italiana di Allergologia e Immunologia Pediatrica“ (SIAIP).

Available in open access.

02. Focus, Scope and Objective

Italian Journal of Pediatric Allergy and Immunology is a quarterly journal that publishes articles relating to pediatric allergy and immunology and vaccinations. It includes editorials, reviews, original articles, clinical cases and articles edited by the SIAIP Commissions.

03. Open Access Policy

As previously reported, Italian Journal of Pediatric Allergy and Immunology provides immediate open access to its content, respecting the idea of its founder that making research freely available to the public supports a greater global exchange of knowledge.

Italian Journal of Pediatric Allergy and Immunology is distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) license: the work can be used by mentioning the author and the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

04. Peer Review Process

Peer reviewed articles include:

  1. Original articles
  2. Reviews
  3. Case reports
  4. Documents from the SIAIP Commissions

The Journal’s Editors will immediately screen all articles submitted for publication. Those articles which fail to reach the scientific standards of the journal or do not fall in its field of interest, may be declined without further review. Articles that meet the requirements of the Journal will be sent to one or two independent peer reviewers and, based on their comments, a recommendation will be made on the acceptability of the manuscript for publication. In some exceptional circumstances, particularly in niche and emerging fields, in which it may not be possible to obtain two independent peer reviewers, the Editor(s) may wish to make a decision to publish based on one peer review report. When making a decision based on one report, Editor(s) are expected to only do so if the peer review report meets the standards set out below.

Every effort is made to provide an editorial decision on the acceptance for publication within 3 months from submission. The reviewers may request a revision of the manuscript. In this case, it is generally understood that only the revised version can be considered for further evaluation under the peer review system. The Editorial Board of the journal is responsible for the selection of referees to conduct the peer-review process.

Reviewers are expected to be professional, honest, courteous, prompt, and constructive. They should:

  • assist in improving the quality of the published paper by reviewing the manuscript objectively, in a timely manner;
  • comment on major strengths and weaknesses of the manuscript as a written communication, independent of the design, methodology, results, and interpretation of the study;
  • maintain the confidentiality of any information supplied by the editor or author and not retain or copy the manuscript;
  • alert the editor to any published or submitted content that is substantially similar to that under review;
  • be aware of any potential conflicts of interest (financial, institutional, collaborative or other relationships between the reviewer and author) and to alert the editor to these.

Manuscripts that do not report primary research or secondary analysis of primary research, such as Editorials, Book Reviews, Letters to the Editor, may be accepted without peer review. Such manuscripts should be assessed by the Editor(s) if the topic is in the area of expertise of the Editor(s); if the topic is not in area of expertise of the Editor(s), the manuscripts should be assessed by at least one independent expert reviewer or Editorial Board Member.

Blinded peer review: Italian Journal of Pediatric Allergy and Immunology uses a single-blind peer review process; that is, author identities are known to peer reviewers, but peer reviewers identities are not revealed to the authors.

All selected members of the Editorial Board and referees must declare any competing interests they may have in reviewing a manuscript. All final decision on acceptability of the manuscripts will be made by the Editor-in-Chief.

05. Submission on line

Submit new article via our new Editorial Manager System 
(Please before submitting your manuscript check Authors Guidelines).

06. Pre- and post-prints

Italian Journal of Pediatric Allergy and Immunology allows and encourages Authors to deposit both their pre- and post-prints in Open-Access institutional archives or repositories. The primary benefit of pre- and post-print self-archiving is to reach larger audience which enhances the visibility and impact of your research.

07. Systematic Reviews

Systematic reviews should be reported using the PRISMA guidelines available at http://prisma-statement.org. A PRISMA checklist and flow diagram (as a Figure) should also be included in the submission material.

08. Clinical Trials

Clinical trials should be reported using the guidelines available at www.consort-statement.org. Italian Journal of Pediatric Allergy and Immunology encourages Authors submitting manuscripts reporting data from a clinical trial to register the trials in any of the following free, public clinical trials registries: www.clinicaltrials.gov http://isrctn.org/.

The clinical trial registration number and the name of the trial register will be published in the paper.

The authors should ensure that they have met the requirements of their funding and regulatory agencies regarding the aggregate clinical trial results they report in clinical trial registries.

It is the authors’ and not the journal editors’ responsibility to explain any discrepancies between results reported in registries and journal publications.

ETHICAL STATEMENT

Italian Journal of Pediatric Allergy and Immunology meets and upholds ethical behavior at all stages of the publication process, by following the standards for best practices by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE ) and the World Association of Medical Editors (WAME).

Following a summary of duties of editors, peer-reviewers, and authors we expect our journals to comply with.

Editors are expected to:

  • act in a balanced, objective and fair way while evaluating manuscripts, considering solely their intellectual merit without regard to authors’ race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy;
  • handle submissions for sponsored supplements or special issues in the same way as other submissions, so that articles are considered without commercial influence;
  • adopt and follow reasonable procedures in the event of complaints of an ethical or conflict nature, in accordance with the policies and procedures of the Journal, where appropriate;
  • give authors a reasonable opportunity to respond to any complaints. Documentation associated with any such complaints should be retained;
  • not disclose any information about a manuscript that is submitted to the journal to anyone other than the corresponding author, reviewers, other editorial advisers, and the publisher, as appropriate.

Reviewers are expected to be professional, honest, courteous, prompt, and constructive. They should:

  • assist in improving the quality of the published paper by reviewing the manuscript objectively, in a timely manner;
  • comment on major strengths and weaknesses of the manuscript as a written communication, independent of the design, methodology, results, and interpretation of the study;
  • maintain the confidentiality of any information supplied by the editor or author and not retain or copy the manuscript;
  • alert the editor to any published or submitted content that is substantially similar to that under review;
  • be aware of any potential conflicts of interest (financial, institutional, collaborative or other relationships between the reviewer and author) and to alert the editor to these.

Authors have an ethical obligation to submit creditable research results for publication. They should:

  • confirm that the manuscript as submitted is not under consideration or accepted for publication elsewhere;
  • confirm that all the work in the submitted manuscript is original and to acknowledge and cite content reproduced from other sources. To obtain permission to reproduce any content from other sources;
  • declare any potential conflicts of interest;
  • maintain records of data associated with their submitted manuscript, and to supply or provide access to these data, on reasonable request;
  • ensure that any studies involving human or animal subjects conform to national, local and institutional laws and requirements and confirm that approval has been sought and obtained where appropriate. Authors should obtain express permission from human subjects and respect their privacy;
  • notify promptly the journal editor or publisher if a significant error in their publication is identified.

PUBLICATION ETHICS AND MALPRACTICE STATEMENT

  1. Ethical Approvals
  2. Informed Consent
  3. Data Availability
  4. Conflict of Interest and Source of Funding
  5. Authorship and Contributorship
  6. Acknowledgements
  7. Plagiarism and Malpractice Policy
  8. AI and AI-assisted technologies policy
  9. Use of generative AI and AI-assisted tools in figures, images and artwork
  10. Corrections and retractions

01. Ethical Approvals

Trial involving human subjects will only be published if such research has been conducted in full compliance with ethical principles, including the Declaration of Helsinki (as revised in 2013) and any additional requirements of the country where the research was carried out.

Manuscripts must be accompanied by a statement that the experiments were conducted with the understanding and written consent of each subject and according to the principles mentioned above. When experimental animals are used, the methods section must clearly state that adequate measures have been taken to minimize pain or discomfort. The experiments should be performed in accordance with the Guide for the Care and Use of Laboratory Animals, established by the National Institute of Health (NIH) in the USA (https://www.ncbi.nlm.nih.gov/books/NBK54050/) , or with the Directive of the Council of the European Communities of 24 November 1986 (86 / 609 / EEC) (https://op.europa.eu/it/publication-detail/-/publication/226db30a-a20f-41bb-90ed-5b2afc7b9962/language-en/format-PDF/source-search),  and in compliance with local laws and regulations. Further guidance on animal research ethics is available from the World Medical Association (2016 revision).

All manuscripts submitted to Italian Journal of Pediatric Allergy and Immunology must include in the Materials and Methods section, an explicit statement in this regard, the name of the Ethics Committee and the reference number, where appropriate. Where a study has been granted an exemption from seeking ethical approval, this should be detailed in the manuscript, together with the name of the Ethics Committee that granted the exemption. Manuscripts may be rejected if the Editors believe that the research was not carried out within an appropriate ethical framework.

If a study has not been submitted to an Ethics Committee before initiation, it is usually not possible to obtain retrospective ethical approval and it may not be possible to consider the manuscript for peer review.

Authors must have obtained Ethics Committee approval and informed patient consent for any investigational use of a new procedure or tool where a clear clinical benefit based on clinical need was not evident prior the treatment.

For retrospective/protocol studies where only aggregate data is analyzed, ethical approval from an appropriate Committee is usually not required, as the data cannot be traced back to specific patients.

The Editors reserve the right to refuse manuscripts in case of doubts about the use of adequate procedures.

02. Informed Consent

For all manuscripts that include details, images, or videos relating to individual subjects, written informed consent of the participants (or their parents or legal guardian in the case of minors) must be obtained for their publication and a statement to this effect must appear in the manuscript.

If the participant is deceased, consent for publication must be obtained from the participant’s closest relative. This documentation must be available to the publishers on request, and will be treated confidentially. In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for image’s publication may not be required. The final decision on the need for consent to publication is at the Editor(s)’ discretion.

Italian Journal of Pediatric Allergy and Immunology strictly follows the ICMJE policy on the Protection of Research Participants. Patients have the right to privacy, which must not be violated without their consent. Once informed consent is obtained, publishers can require authors to provide a copy before making an editorial decision.

03. Data Availability

To promote transparency of the data supporting the results reported in the article, the Journal encourages authors to provide a data availability statement, provided that the research data can be made public. This should be included at the end of the “Materials and Methods” section under a separate “Data availability” subheading. Data availability statement should include information on where data can be found, whether data are deposited on publicly available data research repositories or they are available upon reasonable request to the corresponding author. Such data will not be published as Supplementary Digital Material.

Examples of data availability statements: 1) the data associated with the paper are available in the [NAME] repository; 2) the data associated with the paper are not publicly available but are available from the corresponding author upon reasonable request; 3) the data associated with the paper will be available in the [NAME] repository following an embargo period).

04. Conflict of Interest and Source of Funding

A conflict of interest occurs when any financial interest may influence the content of an article. This does not imply that any financial involvement with a sponsor who has supported research or funded a consultation is problematic.

Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and those most likely to undermine the credibility of the journal, the authors, and of science itself.

All participants in the peer-review and publication process must disclose any relationships that could be viewed as potential conflicts of interest. Disclosure of such reports is also important in relation to editorials and review articles, because it can be more difficult to detect bias in these types of publications than in original research reports.

To promote transparency and avoid any possible prejudice of readers towards the article, each author is required to report any potential conflict of interest both in the Authorship responsibility – Financial disclosure – Copyright transfer form section, and at the end of the manuscript file in the notes under the “Conflicts of interest” section.

Publishers may use information disclosed in conflict of interest and financial interest statements as a basis for editorial decisions and may request additional information regarding competing interests.

Potential conflicts of interest may be directly or indirectly related to an article and may include, but are not limited to, research funding from organizations that have a financial interest in the results of publication, financial support for participation in symposia or educational programs, advisory relationships, employment funds, personal financial interests. Disclosure of the conflict of interest should follow the recommendations of the ICMJE.

All submitted manuscripts must include a ‘conflict of interest’ section listing all competing interests (financial and non-financial). In the absence of a conflict of interest, the Authors should state at the end of the manuscript file in the notes in the “Conflicts of interest” section: “The Authors declare that they have no conflict of interest”.

All sources of funding must be mentioned at the end of the manuscript file in the notes in the “Funding” section. The role of the possible sponsor in the study design, acquisition, analysis and interpretation of data must be briefly described in the drafting the manuscript. If the sponsor was not specifically involved in the research, this should be disclosed.

05. Authorship and Contributorship

Italian Journal of Pediatric Allergy and Immunology endorses the ICMJE criteria to define the roles of Authors and Contributors to justify authorship.

According to the ICMJE, the criteria for authorship should be based on: 1) substantial contributions to the conception or design of the work; or to the acquisition, analysis, or interpretation of data for work; 2) draft the article or revise it critically for important intellectual content; 3) final approval of the version to be published and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Authors should meet conditions 1, 2, 3 and 4. It is a requirement that all authors have been appropriately accredited at the time of manuscript submission. Contributors who do not qualify as authors should be credited in the Acknowledgements section.

06. Acknowledgements

Contributors to the manuscript other than credited authors should be specified in the acknowledgements section.  Details of the funding source for the study and any potential conflict of interests, if any, should also be included.

07. Plagiarism and Malpractice Policy

Authors must avoid any unethical and improper actions such as plagiarism, simultaneous submission, falsification, fraudulent authorship, copyright infringement, hiding of competing interests, etc. For further information:

  1. Committee on Publication Ethics (COPE). (2017). Core practices. https://publicationethics.org/core-practices
  2. International Committee of Medical Journal Editors (ICMJE). (n.d.). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. https://www.icmje.org/icmje-recommendations.pdf
  3. WAME Publication Ethics Committee. (n.d.). Recommendations on publication ethics policies for medical journals. World Association of Medical Editors (WAME). http://wame.org/recommendations-on-publication-ethics-policies-for-medical-journals

By submitting a manuscript, authors certify that the submission is free of the aforementioned unfair malpractices, adheres to ethical standards, applicable laws and regulations, and that all necessary consents, permissions, and legal documents are prepared. The authors take full responsibility for the opinions, results, discussions, and conclusions provided in the articles and to resolve any issues that may arise from the inclusion of copyrighted content without the necessary authorization. 

Plagiarism is the use of the intellectual property of existing literature, in whole or in part, by copying as is or translating from another language. Plagiarism or repetition of another text is prohibited, even if it precedes the author’s publication. Exceptionally, i) works derived from the author’s university thesis; ii) preliminary studies by the author presented at a conference or as a poster. Furthermore, findings from a database and clinical trial registries may be repeated in more than one article. If in doubt, authors should consult the editorial team office before submission.

To prevent plagiarism, all submissions undergo an initial screening. When ethical misconduct, such as plagiarism, is discovered in a manuscript under review or a published article, editors must investigate the details of the case and take necessary actions using the appropriate COPE flowcharts, even if the misconduct is discovered years after publication. In such cases, the manuscript under review can be immediately rejected, the published article can be retracted, and the relevant legal bodies can be informed about the details of the case.

08. Artificial Intelligence (AI) and AI-assisted technologies policy

Where authors use AI and AI-assisted technologies in the writing process, these technologies should only be used to improve readability and language of the manuscript and not to replace key writing tasks. The application of the technology should be carried out with human supervision and control and all work should be carefully reviewed and edited.

Authors should disclose the use of AI and AI-assisted technologies in their manuscript and a statement will appear in the published article.

Authors should not list AI and AI-assisted technologies as an author or co-author, or cite AI as an author.

09. The use of generative AI and AI-assisted tools in figures, images and artwork

Pacini Editore does not allow the use of generative AI or AI-assisted tools to create or alter images in submitted manuscripts. This can include enhancing, darkening, moving, removing, or introducing a specific feature within an image or figure.

The only exception is if the use of AI or AI-assisted tools was part of the research design or methods. In this case, such use must be described in a reproducible way in the methods section, and also include an explanation of how they were used.

The use of generative AI or AI-assisted tools in the production of graphical abstracts is not permitted

10. Corrections

The correction procedure depends on the publication phase of the article, but in any case a correction notice will be published as soon as possible:

10.1 Online First publication

When the first online version of a given article is published, the Editorial team will evaluate the possibility of replacing this version with an updated version that corrects the error and notes the changes made, by means of a correction notice at the end of the article.

10.2 Publication in an issue

If the article has already appeared online, the online version of the article will link to the correction notice, and vice versa.

11. Retractions

Journal editors will consider withdrawing an article at the request of the Authors, or in case of evidence of unreliable data or results, plagiarism, duplicate publications and unethical research.

11.1 Publication in an issue

A replacement version of the article will be posted containing just the metadata, with a retraction note replacing the original text. The PDF will be replaced with a version watermarked with “Retracted”, but the original text will remain accessible.

In rare cases, we may need to remove the original content for legal reasons. In these cases the metadata (title and authors) will be left and the text will be replaced by a note informing that the article has been removed for legal reasons. A recall notice will be posted online.

Retraction notices are indexed and linked to the original records in Medline.

https://publicationethics.org/retraction-guidelines

 

******************

 

SIAIP and Pacini Editore srl inform readers and users of the Italian Journal of Pediatric Allergy and Immunology, that the published articles reflect only the research and the opinion of the authors signing the contents. These articles therefore do not represent and do not in any way constitute indications or guidelines of MSM and AIM itself. This differs from the texts and contents that are explicitly declared as official institutional matrix and published in the appropriate sections of the Journal, which are dedicated to the Guidelines of MSM and AIM.

The Italian Journal of Pediatric Allergy and Immunology is sent to SIAIP members, subscribers, doctors, health professionals, exclusively for professional training and improvement and to inform and promote activities and products / services, strictly related to the professional activities of users, always ensuring a strong affinity between the message and the user's interest. Please read the Privacy Policy at the following link: https://www.riaponline.it/about/privacy.

For communications/information: privacy@pacinieditore.it